Rifabutin

Primary Uses

Rifabutin is an antibiotic medication used to prevent and treat certain bacterial infections. Its main uses include:

• Prevention of MAC Disease: It is used to prevent disseminated Mycobacterium avium complex (MAC) in people with advanced HIV infection. MAC is a serious infection that can spread throughout the body in individuals with weakened immune systems.
• Treatment of Tuberculosis (TB): Rifabutin may be prescribed as part of a multi-drug regimen to treat active tuberculosis, particularly in patients who are also being treated for HIV or those who cannot take other similar antibiotics.

This medication is only effective against bacterial infections. It is not used to treat viral infections like the flu or the common cold.

Mechanism of Action

Rifabutin belongs to a class of medications known as antimycobacterials. It works by interfering with the biological processes that bacteria need to survive and reproduce.

The medication targets a specific enzyme within the bacteria that is responsible for creating RNA, which is essential for making proteins. By blocking this enzyme, rifabutin prevents the bacteria from building the proteins they need to maintain their structure and multiply. This action either kills the bacteria directly or stops them from spreading, which allows the body's immune system to better manage the infection.

Key points about how this medication functions include:

• Selective targeting: It is designed to disrupt bacterial growth while leaving human cells largely unaffected.
• Bacterial focus: Because it specifically targets bacterial enzymes, it is not effective against viruses, such as those that cause the common cold or flu.
• Prevention and treatment: It is often used to prevent specific bacterial infections from developing in individuals with weakened immune systems by keeping bacterial levels low.

Common Side Effects

Rifabutin may cause several common side effects. A frequent and harmless effect is the orange-red or brownish discoloration of urine, feces, saliva, sputum, sweat, and tears. This discoloration may permanently stain soft contact lenses.

Other common side effects include:

• Nausea or vomiting
• Stomach pain, gas, or belching
• Diarrhea
• Headache
• Muscle pain
• Skin rash
• Changes in taste

Serious Side Effects

Some side effects can be serious. Seek medical attention immediately if you experience any of the following:

• Eye inflammation (uveitis): Symptoms include eye pain, redness, or blurred vision.
• Low blood cell counts: Fever, chills, sore throat, or other signs of infection, as well as unusual bruising or bleeding.
• Liver problems: Yellowing of the eyes or skin (jaundice), dark urine, or severe fatigue.
• Severe skin reactions: A widespread rash, hives, or skin peeling.
• Severe intestinal conditions: Persistent diarrhea, stomach cramps, or blood in the stool.
• Joint pain: New or worsening pain in the joints.

Hypersensitivity and Contraindications

Rifabutin is contraindicated in individuals with a known history of hypersensitivity to this drug or any other rifamycins, such as rifampin. Allergic reactions may occur and require immediate medical attention.

Risk of Uveitis

Inflammation of the eye, known as uveitis, has been reported with rifabutin use. This risk increases when the medication is taken at higher doses or in combination with certain other drugs that increase rifabutin concentrations in the blood, such as clarithromycin or fluconazole. Symptoms of uveitis include eye pain, redness, and vision changes.

Active Tuberculosis and Drug Resistance

Before starting rifabutin for the prevention of Mycobacterium avium complex (MAC) disease, healthcare providers must rule out active tuberculosis (TB). If rifabutin is administered alone to a patient with active TB, the bacteria may develop resistance to both rifabutin and rifampin, complicating future treatment.

Blood and Liver Monitoring

Rifabutin can cause significant decreases in white blood cell counts (neutropenia) and blood platelets (thrombocytopenia). Regular blood tests are typically performed to monitor these levels during treatment. Liver function monitoring may also be necessary, particularly for patients with a history of liver impairment.

Drug Interactions

Rifabutin is a known inducer of certain liver enzymes, which can lead to significant interactions with many other medications. It may reduce the effectiveness of hormonal contraceptives, including birth control pills, implants, and injections. Using non-hormonal backup methods of contraception is generally advised during treatment.

Body Fluid Discoloration

This medication may cause a brownish-orange discoloration of the skin and body fluids, including urine, feces, saliva, sputum, perspiration, and tears. While this effect is harmless, the medication can permanently stain soft contact lenses, which should not be worn during treatment.

Diarrhea and Colitis

Treatment with antibacterial agents like rifabutin can alter the normal flora of the colon, leading to the overgrowth of Clostridioides difficile. This can result in Clostridioides difficile-associated diarrhea (CDAD), which ranges in severity from mild diarrhea to life-threatening inflammation of the colon.

Pregnancy

There are no adequate and well-controlled studies of rifabutin use in pregnant women. While animal studies at very high doses have shown some potential for fetal harm, these results do not always predict how the drug will affect humans. Because the risks are not fully known, healthcare providers typically only prescribe rifabutin during pregnancy if it is clearly needed for the patient's health.

Breastfeeding

It is not known whether rifabutin passes into human breast milk. Because many drugs are excreted in milk and there is a potential for side effects in nursing infants, a decision must be made whether to stop breastfeeding or stop taking the medication. Patients should discuss the importance of the treatment versus the risks of infant exposure with their healthcare provider.

Available Forms

Rifabutin is currently available in the following form:

• Oral Capsule

This medication is taken by mouth as directed by a healthcare professional.

FDA Approval and Indications

Rifabutin was approved by the U.S. Food and Drug Administration (FDA) for the prevention of disseminated Mycobacterium avium complex (MAC) disease. This is a serious bacterial infection that typically occurs in people with advanced human immunodeficiency virus (HIV) infection.

Regulatory Status

Rifabutin is classified as a prescription-only medication. It belongs to the antimycobacterial class of drugs. According to the FDA-approved labeling, the medication is intended to prevent infection in high-risk patients rather than treat active MAC disease or other types of tuberculosis on its own.

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for this drug. Regulatory guidance emphasizes that the medication should be used strictly as directed to prevent the development of drug-resistant bacteria and to maintain the effectiveness of the treatment.

Generic and Brand-Name Options

Rifabutin is available as a generic medication and under the brand name Mycobutin. Generic versions are typically less expensive than brand-name drugs while providing the same therapeutic effect.

Insurance and Medicare Coverage

Most health insurance plans and Medicare Part D cover rifabutin. The out-of-pocket cost for the patient depends on the specific plan's formulary, which determines the copayment or coinsurance amount.

Factors Influencing Cost

Several factors can affect the final price of rifabutin, including:

• The pharmacy location and whether it is an in-network provider for your insurance.
• The dosage and quantity of capsules prescribed.
• Eligibility for patient assistance programs or pharmacy discount cards.